logo
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the 'Company'), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has received 510(k) clearance for its ClearPoint Navigation Software Version 3.0.
'As we prepare for the wave of new patients that will be treated with cell and gene therapies in the years ahead, it is crucial that ClearPoint helps healthcare providers be ready by providing simplified workflows, offering solutions to increase surgical capacity and expanding access to our hardware and software,' commented Joe Burnett, President and CEO at ClearPoint Neuro. 'The newest ClearPoint 3.0 platform is designed to do exactly that by offering one of the fastest and most accurate navigation systems available while enabling the flexibility to be used in both the MRI suite and the operating room. Today, more than nighty-five percent of all stereotactic procedures in the United States take place in the operating room using Computed Tomography (CT) as the imaging modality. Using CT, the ClearPoint Software now supports the entire operating room procedure, eliminating the need for additional third-party navigation systems. Hospitals can use ClearPoint in either or both settings, benefiting from a consistent workflow that streamlines procedures and builds proficiency. We believe that this single, flexible solution will benefit our 50+ global biopharma partners with the potential to standardize cell and gene therapy delivery around the world, starting here in the United States.'
ClearPoint Navigation Software Version 3.0 introduces an intraoperative CT workflow that builds on over a decade of experience in enabling MRI-guided stereotactic procedures. While previous versions of ClearPoint software supported MRI-guided workflows exclusively, the latest release extends ClearPoint navigation capabilities to the operating room. With compatibility for intraoperative CT and Conebeam CT imaging, this enhancement broadens access to precision-guided neurosurgery for facilities without intraoperative MRI capabilities. The ClearPoint Navigation Software Version 3.0 when used in conjunction with the SmartFrame® XG stereotactic frame, is intended to provide precise stereotactic guidance when placing instruments or devices during neurosurgical procedures. These procedures include biopsies, catheter and electrode insertion including deep brain stimulation (asleep or awake) lead placement.
The Company plans to initiate a limited market release for ClearPoint Navigation Version 3.0 in Q1 2025, with a planned full market release in the second half of 2025.
About ClearPoint Neuro
ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company uniquely provides both established clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company's flagship product, the ClearPoint Neuro Navigation System, has FDA clearance and is CE-marked. ClearPoint Neuro is engaged with healthcare and research centers in North America, Europe, Asia, and South America. The Company is also partnered with the most innovative pharmaceutical/biotech companies, academic centers, and contract research organizations, providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide. To date, thousands of procedures have been performed and supported by the Company's field-based clinical specialist team, which offers support and services to our customers and partners worldwide. For more information, please visit www.clearpointneuro.com.
Forward-Looking Statements
This press release contains forward-looking statements within the context of the federal securities laws, including the Company's expectation for the future market of its products and services, and other performance and results. These forward-looking statements are based on management's current expectations and are subject to the risks inherent in the business, which may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: global and political instability, supply chain disruptions, labor shortages, and macroeconomic and inflationary conditions; future revenue from sales of the Company's products and services; the Company's ability to market, commercialize and achieve broader market acceptance for new products and services offered by the Company; the ability of our biologics and drug delivery partners to achieve commercial success, including their use of the Company's products and services in their delivery of therapies; the Company's expectations, projections and estimates regarding expenses, future revenue, capital requirements, and the availability of and the need for additional financing; the Company's ability to obtain additional funding to support its research and development programs; the ability of the Company to manage the growth of its business; the Company's ability to attract and retain its key employees; and risks inherent in the research, development, and regulatory approval of new products. More detailed information on these and additional factors that could affect the Company's actual results are described in the 'Risk Factors' section of the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and the Company's Quarterly Report on Form 10-Q for the three months ended September 30, 2024, both of which have been filed with the Securities and Exchange Commission, and the Company's Annual Report on Form 10-K for the year ended December 31, 2024, which the Company intends to file with the Securities and Exchange Commission on or before March 31, 2025. The Company does not assume any obligation to update these forward-looking statements.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AI Code Review Pioneer CodeRabbit Recognized in Redpoint's InfraRed 100
AI Code Review Pioneer CodeRabbit Recognized in Redpoint's InfraRed 100

Yahoo

time30 minutes ago

  • Yahoo

AI Code Review Pioneer CodeRabbit Recognized in Redpoint's InfraRed 100

InfraRed Report Shows Cloud Infrastructure Powers Virtually All Software WALNUT CREEK, Calif., June 10, 2025--(BUSINESS WIRE)--CodeRabbit, the most advanced AI code review platform, today announced its inclusion on the Redpoint InfraRed 100. This prestigious list highlights the 100 up-and-coming private companies in Cloud Infrastructure, showcasing the future leaders set to revolutionize the market. CodeRabbit integrates foundational gen-AI models with multiple data sources that enhance the code context, leading to higher quality reviews, cutting down code review time and bugs in half. CodeRabbit's AI code reviews have been rapidly adopted by customers including The Linux Foundation, Groupon, Chegg, Trivago, and many more. Redpoint Ventures, a top-tier venture capital firm with a diverse portfolio including companies such as Snowflake, Twilio, Looker, Nextdoor, Ramp, Stripe, Nubank, HashiCorp, Netflix, Hims, and more, launched this list in 2023 to showcase the exceptional builders in the industry who are creating industry-transforming companies. To commemorate this achievement, CodeRabbit's co-founder and CEO Harjot Gill will join Redpoint at Nasdaq with other InfraRed 100 leaders to discuss the evolving landscape of cloud infrastructure. "We are honored to be recognized in the InfraRed 100, especially alongside such a distinguished group of cloud infrastructure companies. We founded CodeRabbit with the mission to transform code reviews with AI to help developers automate the tedious parts of software development. We believe that AI, when augmented with appropriate context and implemented with the right guardrails will identify defects that are hard to catch in manual reviews, leading to fewer bugs and faster release cycles," said Gill. "We thank the team at Redpoint for this recognition and congratulate all the companies on the list." For the complete list of companies included on this year's InfraRed 100 list and to read the full InfraRed industry report, click here. About CodeRabbit CodeRabbit is the pioneer of the AI code review category, evolving the historically manual and low-context review process into a more automated, context-aware workflow that's compatible with today's highly dynamic CI/CD pipeline. CodeRabbit enables engineering organizations that use code-gen agents to generate code at a fast pace to identify code quality issues before production, reducing code review cycles and allowing developers to reclaim valuable time. Headquartered in Walnut Creek, California, and funded by CRV, Flex Capital, and Engineering Capital, CodeRabbit is on a mission to transform code quality, security, and developer productivity with AI. Try CodeRabbit free at: About Redpoint Ventures: Redpoint has partnered with visionary founders to create new markets and redefine existing ones since 1999. We invest in startups across the seed, early and growth phases, and we're proud to have backed over 615 companies—including Snowflake, Looker, Kustomer, Twilio, 2U, DraftKings, Duo Security, HashiCorp, Stripe, Guild, HomeAway, Heroku, Netflix, and Sonos—with 183 IPOs and M+A exits. Redpoint manages $8.0 billion across multiple funds. For more information visit: View source version on Contacts Heather FitzsimmonsMindshare PR650-279-4360heather@

Kanye West Once Gifted Kim Kardashian Stocks In Apple, Netflix, Amazon And Disney — And His Financial Foresight Continues To Benefit Her Wealth
Kanye West Once Gifted Kim Kardashian Stocks In Apple, Netflix, Amazon And Disney — And His Financial Foresight Continues To Benefit Her Wealth

Yahoo

time36 minutes ago

  • Yahoo

Kanye West Once Gifted Kim Kardashian Stocks In Apple, Netflix, Amazon And Disney — And His Financial Foresight Continues To Benefit Her Wealth

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Even though Kanye West and Kim Kardashian's relationship is a thing of the past, West's investments in stocks for his ex-wife continue to thrive, significantly boosting her financial portfolio. What Happened: Despite their high-profile divorce, West's financial decisions continue to influence Kardashian's wealth. According to Forbes, her net worth currently stands at $1.7 billion. Kanye made strategic stock investments on Kardashian's behalf before their separation, many of which have seen impressive returns. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — In 2017, Kardashian revealed that her husband, West, gave her an extraordinary Christmas gift: stock worth hundreds of thousands of dollars in major companies like Walt Disney Co. (NYSE:DIS), Netflix Inc. (NASDAQ:NFLX), Apple Inc. (NASDAQ:AAPL), Inc. (NASDAQ:AMZN) and Adidas (OTC:ADDYY). If an investor had mirrored West's gift to Kardashian by investing $1,000 in each of these companies, here's how that portfolio would have performed:Disney (DIS) $104.39 $112.53 $1,077.97 +7.80% Netflix (NFLX) $189.94 $1,250.52 $6,583.76 +558.38% Apple (AAPL) $41.07 $200.63 $4,885.07 +388.51% Amazon (AMZN) $58.42 $207.91 $3,558.88 +255.89% Adidas (ADDYY) $94.26 $120.46 $1,277.95 +27.80% Note: Stock prices from 2017 are adjusted to reflect splits and dividends. Over the past five years, Disney shares have declined by 9.85%, while Netflix has surged 198.03%. Apple shares have risen 142.07%, Amazon is up 67.47% and Adidas has fallen by 19.25%, according to data from Benzinga It's Important: Kardashian is a television personality, entrepreneur and social media icon who first gained widespread recognition in 2007 through the E! reality series "Keeping Up with the Kardashians," which chronicled the lives of the Kardashian-Jenner family. Beyond television, she has built a successful business empire with ventures like KKW Beauty, KKW Fragrance and the shapewear brand SKIMS. West, on the other hand, is an American rapper, producer, entrepreneur and fashion designer. In October 2021, he legally changed his name to Ye, citing its spiritual significance. Widely regarded as one of the most influential musicians of his generation, Ye has sold over 135 million records globally, according to People. Ye is known for his bold public statements and widely publicized personal life. In the fashion world, he founded the Yeezy brand. Read Next: In terms of getting money back, these bank accounts put traditional checking and savings accounts to shame. Maximize saving for your retirement and cut down taxes: Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. Photo Courtesy: Tinseltown on This article Kanye West Once Gifted Kim Kardashian Stocks In Apple, Netflix, Amazon And Disney — And His Financial Foresight Continues To Benefit Her Wealth originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Serena Williams Joins Stagwell's (STGW) SPORT BEACH 2025 Roster
Serena Williams Joins Stagwell's (STGW) SPORT BEACH 2025 Roster

Yahoo

timean hour ago

  • Yahoo

Serena Williams Joins Stagwell's (STGW) SPORT BEACH 2025 Roster

NEW YORK, June 10, 2025 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to transform marketing, today announced the addition of tennis icon and trailblazer Serena Williams to its SPORT BEACH 2025 roster. On the heels of announcing her and her sister Venus' new podcast with X, Williams will join X CEO Linda Yaccarino on Thursday, June 19 for a fireside chat at SPORT BEACH to discuss her vision for a new model of athlete-entrepreneur. To register, view the full programming calendar, and see the full roster of leaders, innovators, and cultural influencers joining SPORT BEACH 2025, visit Stagwell invites brands, athletes, sports leagues, media platforms and other interested parties to reach out to sportbeach@ to get involved. About StagwellStagwell is the challenger holding company built to transform marketing. We deliver scaled creative performance for the world's most ambitious brands, connecting culture-moving creativity with leading-edge technology to harmonize the art and science of marketing. Led by entrepreneurs, our specialists in 45+ countries are unified under a single purpose: to drive effectiveness and improve business results for our clients. Join us at ContactKara GelberPR@ View original content to download multimedia: SOURCE Stagwell Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store